|
|
 |

[08/11/2006]
Democratic Republic of Congo | |
 |

Dr. Francis LOUIS, Yaoundé, Cameroon
|  |
General country information
- Area:
2,345,410 km2 - Population:
62,660,000 inhabitants (estimate dated June 2006) - Official
language: French - Currency:
Congolese Franc since June 17, 1998 (on January 6, 2005, 1 US
dollar = CDF 417) - Border
countries: Angola (Cabinda), Congo, Central African
Republic, Sudan, Rwanda, Burundi, Uganda, Tanzania, Zambia and
Angola - Capital:
Kinshasa (3-6 million inhabitants) - Main
cities: Mbuji-Mayi, Matadi, Kisangani, Lubumbashi,
Mbandaka, Kikwit, Gbadolite and Kolwezi.
The country is largely composed of a central basin, drained by
the Congo and its affluents.
In the Western part of the country, the topography (600 to 900 m)
is composed of Mayombe and the Cristal Mountains. In the South, the
Katanga plateaus reach an altitude of 1,500m, while the country’s
highest summits are found in the East, in Kivu (Rwenzori Mountains,
which reach 5,019m and the Virunga volcanic range, reaching over
3,000m).
In the basin, the DRC enjoys an equatorial climate that is always
hot and humid. The climate turns tropical in the Northern part of
the country and in the Southern part from the 5th parallel.
However, because of the vast surface area of this subcontinent,
significant variations are observed, with a dry season that
increases from the West to the East and from the North to the South
(Fig. 2). When it exists, this dry season runs from May through
August.
Moyennes sur 30 ans (1961-1990) = Averages over 30 years
(1961-1990)
Précipitations (mm) = Precipitation (mm)
Evapotranspiration (mm) = Evapotranspiration (mm)
Température moyenne = Average temperature
| Epidemiological facies
Malaria is omnipresent, except at altitudes over 1,800m (Fig.
3).
The following is observed :
- regions with constant transmission, with the population
developing a high level of premunition (basin);
- regions with seasonal transmission, where the increase in
clinical cases follows vectors’ seasonal peaks (Southern part of
the country);
- epidemic regions, in the valleys of the mountainous regions
(Kivu, Katanga).
Most of the country is hyperendemic (62), with average
parasitological indices of 75% in children under 3 years old, 68%
in 4-15 years old and 22% in adults (01).
In Kivu, malaria is meso-endemic: the parasitological index is less
than 30% in children under 5 years old and around 40% in older
subjects (26). Malaria accounts for 12% of the causes of death. In
the general population, malaria-related mortality is 3 per 1,000
annually. In 1-4 years old, it is 6 per 1,000 and in children under
12 months old, it is 18 per 1,000 (20).
In the city of Kinshasa, huge differences in incidence and
prevalence can be seen, depending on the geographic location
(distance from the river and its affluents), level of urbanization
(transmission is very low in the city center) and social standing
of the residents of the different areas (22, 62). A study carried
out by Mulumba et al. gives Kinshasa a parasitological index of 50%
in children (22). Malaria is the leading cause for pediatric
mortality (15% of deaths), far ahead of measles (6%) and
gastroenteritis (3%) (19)
| Parasites
Plasmodium falciparum is the predominant malarial species.
It is found, both alone and in combination, in 98% to 100% of
parasitological diagnoses (03, 08, 37, 57). Plasmodium malariae is the second most prevalent malarial
species. It is found in 6% of the blood samples taken in Kinshasa
(08) and in 32% of blood samples taken in Uvira, in South Kivu
(08). Plasmodium vivax is identified at a rate of 1.2% to 9%
(03, 08) and Plasmodium ovale at a rate of 0.6%
(08).
Three specific cases:
- in the Pygmies of the Eastern province, in the Eastern part of
the DRC, Price et al. found Plasmodium falciparum
and Plasmodium malariae at an equal frequency
(04);
- in two 4 year-old twin sisters, Galeazzi et al. describe a triple
infestation with Plasmodium
falciparum, Plasmodium malariae
and Plasmodium ovale (56);
- Comellini et al. describe a case of congenital malaria
with Plasmodium vivax (46).
| Chemoresistance
Resistance to chloroquine According to Moran et al., resistance to chloroquine apparently
appeared in the DRC in 1982, at the Eastern border, and, from
there, it evidently spread throughout the entire country (22).
Delacollette et al. confirm that in 1982, three Americans, members
of the Peace Corps working in Kivu, contracted a
chloroquine-resistant malaria (20).
Resistance is mentioned in 1985 by Ngimbi et al., in a study
conducted in Kinshasa in 1984: out of 101 patients treated with
chloroquine at a dose of 25 mg/kg given over three days, the rate
of recovery was 95%. A strain was confirmed to be resistant in
vitro (11).
The same year, in an in vivo and in vitro study carried out in
Kinshasa and Mbuji-Mayi, Phuc Nguyen-Dinh et al. did not observe
any resistance (09). However, in 1986, they observed a level of
resistance in vitro of 82% (13).
In vivo in 1988, Paluku et al. observed levels of sensitivity to
chloroquine at a dose of 25 mg/kg over three days of 92% in
children under 5 years old in Equador and of 44% only in Kinshasa
(13). In 1989, the same authors observed sensitivity in vivo of
53.5 % in Kisangani, 19.5% in Bas-Congo and 55.5% in Bandundu
(17).
In 1997, in vivo sensitivity to chloroquine at a dose of 25 mg/kg
over three days was still 61%. It was 55% in 2003 (53); this
inefficacy most likely explains that in Kinshasa and Kivu, regular
treatment with chloroquine during pregnancy no longer prevents
dysmaturity or low birth weight (54, 55). Resistance to other antimalarial drugs 1. Amodiaquine:
No data published. 2. Quinine:
In 1989, in vivo sensitivity to quinine was 93.9% in Kisangani,
91.5% in Bas-Congo and 97.6% in Bandundu (17).
Out of 34 children hospitalized with severe malaria and treated
intravenously with quinine, fever clearance time was 44.1 hours and
parasite clearance time was 59.6 hours (18).
In vitro, no plasmodium strain was found to be resistant to quinine
(09). 3. Mefloquine:
No data published. 4. Halofantrine:
The study carried out by Mashako et al. in 1990 covered only 54
pediatric cases treated with halofantrine. Efficacy was 100%, fever
clearance time was 18 hours and parasite clearance time was 37
hours (25). 5. The sulfadoxine-pyrimethamine
combination:
In 1989, Paluku et al. observed an efficacy of the
sulfadoxine-pyrimethamine combination in 95.8% of cases in
Kisangani, 97.8% in Bas-Congo and 100% in Bandundu (17).
In 2003, Kazadi et al. noted 7.5% failures out of 333 treatments
with the sulfadoxine-pyrimethamine combination for uncomplicated
Plasmodium falciparum malaria (53).
6. Artemisinine
derivatives:
No data published.
| Vectors and the fight against vectors
According to Karch et al., the anopheline fauna of Kinshasa
comprises seven
species: Anopheles gambiae is the
species encountered most frequently (93.3%) and is responsible for
one bite per person per night (b/p/night) in the city, against 26
in rural areas. The average annual inoculation rate is 197 infested
bites per person per year (ib/p/year). Anopheles funestus,
Anopheles paludis, Anopheles Hancocki, Anopheles coustani,
Anopheles brunnipes and Anopheles nili are much
more rare (29).
Coene has shown that in the city of Kinshasa, Culex mosquitoes are
responsible for 121 b/p/night and Anopheles gambiae
are responsible for 5.1 b/p/night. In rural
areas, Anopheles gambiae is responsible for 13.3
b/p/night and Anopheles funestus is responsible for 2.4 b/p/night.
The other species play a much smaller role: Anopheles nili (0.4
b/p/night), Anopheles brunnipes (0.7 b/p/night), Anopheles
paludis (0.4 b/p/night) and Anopheles hancocki
(0.2 b/p/night) (27).
In Bandundu, Karch and Mouchet have shown that Anopheles
paludis is the most prevalent (55.1%), followed
by Anopheles gambiae (27.8%), Anopheles
funestus (11.2%), Anopheles moucheti (4.4%)
and Anopheles nili (1.5%) (33).
According to Bafort, Anopheles marshalli apparently
plays a role in malaria transmission in the Eastern part of the
country (10). Anopheles gambiae (68.3%), Culex (28.1 %)
and Anopheles funestus (28.1 %) larvae have been
isolated in the ponds of Kivu. Anopheline density is greater as the
pond is shadier (59, 60). In Kinshasa, using coils to fight mosquitoes inside homes has
not proved effective: Coene et al. demonstrated that this practice
was lowering the rate of bites by only 18% to 30% (16).
On the other hand, on the Bateke Plateaus near Kinshasa, the
persistent use of insecticide-treated mosquito nets for beds has
caused the number of Anopheles gambiae to drop by 94%
and the number of ib/p/year to drop by 98% (37).
| Management of malaria:
Malaria is an especially difficult burden for the populations in
the Democratic Republic of the Congo.
Accordingly, an annual average of nine febrile illnesses have been
observed per person in children under 5 years old and four febrile
illnesses per person in those over 5 years old. Fever-related
mortality in children under 5 years old is 3 p. 1000 (Health for
All Project, 1985).
Malaria infection is found in 37% of primigravida and in 24% of all
pregnant women (13).
Meuris et al. have shown that 18% of pregnant women with a malaria
infection give birth to low birth-weight newborns
(35). Families respond as best they can, spending approximately 25% of
their income: 85.6% buy coils, 55.5% use aerosol insecticides and
38.6% have mosquito nets for beds (28). Forty-four percent of
children receive presumptive treatment for malaria when they have a
fever (36).
| Recommendations for travelers:
From 1952 to 1961, Belgium had an average of 35 cases of malaria
imported from Zaire (former name of the Democratic Republic of the
Congo) each year, with extremes of seven in 1958 and 79 in 1952
(05). From 1985 to 1995, the annual average was 289 cases, with
extremes of 208 in 1985 and 423 in 1994 (50). More recently, a study conducted concerning missionaries in the
Northeastern part of the county showed that 62% of them were taking
a chemical prophylaxis: either chloroquine alone (25.8%),
chloroquine-proguanil combination (45.2%),
chloroquine-pyrimethamine combination (3.2%), mefloquine alone
(3.2%), pyrimethamine alone (3.2%), proguanil alone (19.4%), or
pyrimethamine-dapsone combination (1.6%)
(47). In its 2006 edition of health recommendations for travelers, the
Institut français de veille sanitaire (French Health Watch
Institute) classifies the Democratic Republic of the Congo in group
three of “countries with a high prevalence of resistance to
chloroquine or multiple resistance” (63).
This means that the recommended chemical prophylaxis is:
- for adults: atovaquone-proguanil combination, mefloquine or
doxycycline;
- for pregnant women: atovaquone-proguanil combination or
mefloquine;
- for children: atovaquone-proguanil combination, mefloquine or
doxycycline, at doses suitable for their weight (weight-related
dose).
Of course, simple measures of individual protection against
anopheline bites are to be remembered: skin repellants and
persistent insecticide-treated mosquito nets for beds.
Prophylaxis for malaria is no longer needed in the mountainous
regions of the country (Kivu) above 1,800 meters.
In the rest of the country, chemical prophylaxis is not necessary
for short stays of less than seven days, if mosquito-protection
rules are followed carefully and if you are able, during the months
following return to a malaria-free area, to visit a doctor
immediately in the event of a fever, informing him or her of your
travels to a malaria-stricken area.
| Bibliographical references:
01 – Duren AN – essai d’étude sur l’importance du paludisme dans
la mortalité au Congo belge – Ann. Soc. belge Med. Trop. 1951 ; 31
: 129-47.
02 – Chardome M, Janssen PJ – Enquête sur l’incidence malarienne
par la méthode dermique dans la région de Lubilash (Congo Belge).
Ann. Soc. belge Med. Trop. 1952 ; 32 : 209-11.
03 – Van der Berghe L, Chardome M, Peel E – Traitement antimalarien
suppressif par la chloroquine chez des enfants en milieu coutumier
au Congo Belge. Ann. Soc. belge Med. Trop. 1952 ; 32 : 571-8.
04 – Price DL, Mann GV, Roels OA, Merrill JM – Parasitism in Congo
Pygmies. Am. J. Trop. Med. Hyg. 1963; 12: 383-7.
05 – Limbos P – La pathologie tropicale d’importation en Belgique.
Bull. Soc. Path. Exot. 1964 ; 57 : 767-81.
06 – Motulsky AG, Vandepitte J, Fraser GR – Population genetic
studies in the Congo. I. Glucose-6-Phosphate Deshydrogenase
Deficiency, Hemoglobin S, and Malaria. Am. J. Human Gen. 1966; 18:
514-37.
07 – Buck AA, Anderson RI, MacRae AA, Fain A – Epidemiology of
polyparasitism. I. Occurrence, Frequency and Distribution of
Multiple Infections in rural Communities in Chad, Peru,
Afghanistan, and Zaire. Tropenmed. Parasit. 1978; 29: 61-70.
08 – Ngimbi NP, Beckers A, Wéry M – Aperçu de la situation
épidémiologique du paludisme à Kinshasa (République du Zaïre) en
1980. Ann. Soc. belge Med. Trop. 1982 ; 62 : 121-37.
09 – Phuc Nguyen-Dinh, Schwartz IK, Sexton JD, Bomboto Egumb,
Botomwito Bolange, Kalisa Ruti, Ngimbi NP, Wéry M – In vivo and in
vitro susceptibility to chloroquine of Plasmodium falciparum in
Kinshasa and Mbuji-Mayi, Zaire. Bull. World Health Organ. 1985 ; 63
: 325-30.
10 – Bafort JM – Anopheles marshalli s.l., a secondary vector of
malaria in Africa. Trans. R. Soc. Trop. Med. Hyg. 1985; 79:
566-7.
11 – Ngimbi NP, Wéry M, Henry MC, Mulumba PC – Reponse in vivo à la
chloroquine au cours du traitement du paludisme à Plasmodium
falciparum en région suburbaine de Kinshasa, Zaïre. Ann. Soc. belge
Med. Trop. 1985 ; 65 suppl. 2 : 123-35.
12 – Gerniers MM, Lamboray JL – Le paludisme dans la population de
Kinshasa : perception du problème, moyens d’action, évaluation.
Ann. Soc. belge Med. Trop. 1985 ; 65 suppl. 2 : 215-22.
13 – Paluku KM, Breman JG, Moore M, Ngimbi NP, Sexton JD, Roy J,
Steketee RW, Weinmann JM, Kalisa-Ruti, Mambu ma-Disu H – Response
of children with Plasmodium falciparum to chloroquine and
development of a national malaria treatment policy in Zaire. Trans.
R. Soc. Trop. Med. Hyg. 1988; 82: 353-7.
14 – Steketee RW, Breman JG – Malaria infection in pregnant women
in Zaire : the effects and the potential for intervention. Ann.
Trop. Med. Parasitol. 1988; 82: 113-20.
15 – Kalenga MK, Mutach K, Nsungula K, Odimba FK, Kabyla I – Les
anémies au cours de la grossesse. Etude clinique et biologique. A
propos de 463 cas observés à Lubumbashi (zaïre). Rev. Fr. Gynecol.
Obstet. 1989 ; 84 : 393-9.
16 – Coene J, Ngimbi NP, Mulumba MP, Wéry M – Ineffectiveness of
mosquito coils in Kinshasa, Zaire. Trans. R. Soc. Trop. Med.
Hyg. 1989; 83: 568-9.
17 – Paluku KM, Ngimbi NP, Mushiya Wa Kalonji, Mambu Ma Disu
H – Efficacité comparative des traitements alternatifs dans
les infections à Plasmodium falciparum au Zaïre. Ann. Soc. belge
Med. Trop. 1989 ; 69 : 25-33.
18 – AE, Phuc Nguyen-Dinh, Davachi F, Yemvula B, Malanda S,
Nzeza M, Williams SB, De Zwart JF, Nzeza M – Intravenous quinine
therapy of hospitalized children with Plasmodium falciparum malaria
in Kinshasa, Zaire. Am. J. Trop. Med. Hyg. 1989 ; 40 : 360-4.
19 – Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J,
Davachi F – Hospital-based surveillance of malaria-related
paediatric morbidity and mortality in Kinshasa, Zaire. Bull. World
Health Organ. 1989 ; 67 : 189-96.
20 – Delacollette C, Van der Stuyft P, Molima K,
Delacollette-Lebrun C, Wéry M – Etude de la mortalité globale et de
la mortalité liée au paludisme dans le Kivu montagneux, Zaïre. Rev.
Epidemiol. Santé Publ. 1989 ; 37 : 161-6.
21 – Moran JS, Bernard KW – The spread of chloroquine-resistant
malaria in Africa. JAMA 1989; 262: 245-8.
22 – Mulumba MP, Wéry M, Ngimbi NN, Paluku K, Van der Stuyft P, De
Muynk A – Le paludisme de l’enfant à Kinshasa (Zaïre). Influence
des saisons, de l’âge, de l’environnement et du standing familial.
Med. Trop. 1990 ; 50 : 53-64.
23 – Colebunders R, Bahwe Y, Nekwei W, Ryder R, Perriens J, Nsimba
K, Turner A, Francis H, Lebughe I, Van der Stuyft P, Piot P –
Incidence of malaria and efficacy of oral quinine in patients
recently infected with human immunodeficiency virus in Kinshasa,
Zaire. J. Inf. 1990; 21: 167-73.
24 – Omanga U, Kapepela K – Epidémiologie du paludisme congénital
en milieu urbain de Kinshasa (Zaïre). Ann. Pediatr. 1990 ; 37 :
195-7.
25 – Mashako MNL, Kingway MP, Kayembe N – Traitement par le
chlorhydrate d’halofantrine du paludisme à Plasmodium falciparum
dans une zone de résistance. Analyse de 54 cas pédiatriques. Ann.
Soc. belge Med. trop. 1990 ; 70 : 25-32.
26 – Delacollette C, Van der Stuyft P, Molima K, Hendrix L, Wéry M
– Indices paludométriques selon l’âge et selon les saisons dans la
zone de santé de Katana, au Kivu montagneux, Zaïre. Ann. Soc. belge
Med. trop. 1990 ; 70 : 263-8.
27 – Coene J – Prospects for malaria control in urban and rural
Kinshasa. Ann. Soc. belge Med. trop. 1991 ; 71 Suppl. 1 :
103-12.
28 – Zandu A, Malengreau M, Wéry M – Pratiques et dépenses pour la
protection contre les moustiques dans les ménages à Kinshasa,
Zaïre. Ann. Soc. belge Med. trop. 1991 ; 71 : 259-66.
29 – Karch S, Asidi N, Manzambi ZM, Salaun JJ – La faune
anophélienne et la transmission du paludisme humain à Kinshasa
(Zaïre). Bull. Soc. Path. Exot. 1992 ; 85 : 304-9.
30 – Delacollette C, Van der Stuyft P, Molima K,
Delacollette-Lebrun C, Wéry M – Demographic findings relevant for
health care planning and evaluation collected through a malaria
control project in the Kivu Mountains, Zaire. Acta Trop. 1992; 52:
189-99.
31 – Karch S, Asidi N, Manzambi ZM, Salaun JJ – Efficacy of
Bacillus sphaericus against the malaria vector Anopheles gambiae
and other mosquitoes in swamps and rice fields in Zaire. J. Am.
Mosq. Control Ass. 1992; 8: 376-80.
32 – Garin B, Salaun JJ, Peyron F, Vigier JP, Busangu J, Perrone J
– Rapid in vivo detection of chloroquine resistance by the
quantitative buffy coat malaria diagnosis system. Am. J. trop. Med.
Hyg. 1992 ; 47 : 446-9.
33 – Karch S, Mouchet J – Anopheles paludis, vecteur important du
paludisme au Zaïre. Bull. Soc. Path. Exot. 1992 ; 85 : 388-9.
34 – Nyirjesy P, Kavasya T, Axelrod P, Fischer PR – Malaria during
pregnancy : neonatal morbidity and mortality and the efficacy of
chloroquine prophylaxis. Clin. Infect. Dis. 1993 ; 16 :
127-32.
35 – Meuris S, Bokumu Bosongo Piko, EErens P, Vanbellinghen AM,
Dramaix M, Hennart P – Gestational malaria : assessment of its
consequences on fetal growth. Am. J. Trop. Med. Hyg. 1993 ; 48 :
603-9.
36 – Vernon AA, Taylor WR, Biey A, Mundeke KM, Chahnazarian A,
Habicht H, Mutombo M, Bakutuvwidi Makani – Changes in use of health
services in a rural health zone in Zaire. Int. J. Epidemiol. 1993 ;
22 : S20-S31.
37 – Karch S, Garin B, Asidi N, Manzambi Z, Salaun JJ, Mouchet J –
Moustiquaires imprégnées contre le paludisme au Zaïre. Ann. Soc.
belge Med. trop. 1993 ; 73 : 37-53.
38 – Hedberg K, Shaffer N, Davachi F, Hightower A, Lyamba B, Paluku
KM, Phuc Nguyen-Dinh, Breman JG – Plasmodium falciparum-associated
anemia in children at a large urban hospital in Zaire. Am. J. Trop.
Med. Hyg. 1993 ; 48 : 365-71.
39 – Boivin MJ, Giordani B, Ndanga K, Maky MM, Manzeki KM, Ngunu N,
Muamba K – Effects of treatment for intestinal parasites and
malaria on the cognitive abilities of schoolchildren in Zaire,
Africa. Health Psychol. 1993; 12: 220-6.
40 – Coene J – Malaria in urban and rural Kinshasa: the
entomological input. Med. Vet. Entomol. 1993 ; 7 : 127-37.
41 – Mulumba PM, Wéry M, Ngimbi NN, Paluku KM, De Muynk A, Van der
Stuyft P – Relation entre parasitémie à Plasmodium et accès fébrile
dans différents groupes de population à Kinshasa, Zaïre. Ann. Soc.
belge Med. trop. 1994 ; 74 : 275-89.
42 – Tshefu K, James MA – falciparum antigen (Pf70) and protection
against malaria in a human population living under intense
transmission in Kinshasa, Zaire. Trop. Med. Parasitol. 1995 ; 46 :
72-6.
43 – Delacollette C, Taelman H, Wéry M – An etiologic study of
hemoglobinuria and blackwater fever in the Kivu mountains,
Zaire. Ann. Soc. belge Med. trop. 1995 ; 75 : 51-63.
44 – Tshikuka JG, Scott ME, Gray-Donald K, Kalumba ON – Multiple
infection with Plasmodium and helminths in communities of low and
relatively high socio-economic status. Ann. Trop. Med. Parasitol.
1996 ; 90 : 277-93.
45 – Rey JL, Cavallo JD, Milleliri JM, L’Hoest S, Soares JL, Piny
N, Coué JC, Jouan A – Les fièvres d’origine indéterminée (FOI) dans
les camps de réfugiés rwandais de la region de Goma au Zaïre
(septembre 1994). Bull. Soc. Path. Exot. 1996 ; 89 : 204-8.
46 – Comellini L, Tozzola A, Baldi F, Brusa S, Serra L, Agostini C,
Scaglia M – Plasmodium vivax congenital malaria in a newborn of a
Zairian immigrant. Ann. Trop. Paediatr. 1998; 18 : 41-3.
47 – Burdon J – Use of malarial prophylaxis amongst a population of
expatriate church workers in Northeast Zaire. J. Travel Med. 1998;
5: 36-8.
48 – Pelloux H – Voyages hors de nos frontières : des parasitoses à
ne pas méconnaître. Rev. Med. Suisse Romande 1999 ; 119 :
93-7.
49 – Tona L, Ngimbi NP, Tsakala M, Mesia K, Cimanga K, Apers S, De
Bruyne T, Pieters L, Totté J, Vlietinck AJ – Antimalarial activity
of 20 crude extracts from nine medicinal plants used in Kinshasa,
Congo. J. Ethnopharmacol. 1999 ; 68 : 193-203.
50 – Muentener P, Schlagenhauf P, Steffen R – Le paludisme importé
(1985 – 1995) : tendances et perspectives. Bull. WHO 1999 ;
77 : 560-6.
51 – Kalenga MK, Nyembo MK, Nshimba M, Foidard JM – Etude de
l’anémie chez les femmes enceintes et les femmes allaitantes de
Lubumbashi (République Démocratique du Congo). J. Gynecol. Obstet.
Biol. Reprod. 2003 ; 32 : 347-53.
52 – Kalenga MK, Nyembo MK, Nshimba M, Foidard JM – Anémie associée
au paludisme et aux helminthiases intestinales à Lubumbashi. Santé
Publique 2003 ; 15 : 413-21.
53 – Kazadi WM, Vong S, Makina BN, Mantshumba JC, Kabuya W, Kebela
BI, Ngimbi NP – Assessing the efficacy of chloroquine and
sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium
falciparum malaria in the Democratic Republic of Congo. Trop. Med.
Int. Health 2003 ; 8 : 868-875.
54 – Mulumba PM, Kabongo MJM, Woto EE – La prévention de
l’hypotrophie foetale échappe désormais à la
chloroquino-prophylaxie dans l’environnement de Kinshasa. Med.
Trop. 2003 ; 63 : 168-70.
55 – Mugisho E, Dramaix M, Porignon D, Mouafo JB, Venbellingem AM,
Hennart P, Meuris S – Ineffectiveness of chloroquine antenatal
prophylaxis in East of Democratic Republic of Congo (RDC). Trop.
Doctor 2003 ; 33 : 177-8.
56 – Galeazzi G, Ardoin F, Petithory JC, Laurent C – Triple
infestation plasmodiale chez deux sœurs jumelles originaires de la
République Démocratique du Congo. Bull. Soc. Path. Exot. 2003 ; 96
: 96-8.
57 – Breman JG, Alilio MS, Mills A – Conquering the intolerable
burden of malaria : what’s new, what’s needed. A summary. Am. J.
Trop. Med. Hyg. 2004 ; 71 suppl. 2 : 1-15.
58 – Kazadi W, Sexton JD, Makengo Bigonsa, Bompela W’Okanga, Way M
– Malaria in primary school children and infants in Kinshasa,
Democratic Republic of the Congo : surveys from the 1980s and 2000.
Am. J. Trop. Med. Hyg. 2004 ; 71 suppl. 2 : 97-102.
59 – Byamungu N, Baluku B – Influence de la configuration des gîtes
sur la densité des larves de moustiques à Lwiro, Sud-Kivu,
République Démocratique du Congo. Med. Trop. 2004 ; 64 :
99-101.
60 – Byamungu N, Baluku B – Effet de l’ombrage sur la reproduction
des moustiques dans les canaux d’évacuation à Lwiro, Sud-Kivu,
République Démocratique du Congo. Med. Trop. 2004 ; 64 :
101-2.
61 – Tona L, Cimanga RK, Mesia K, Musuamba CT, De Bruyne T, Apers
S, Hernans N, Van Miert S, Pieters L, Totté J, Vlietinck AJ – In
vitro antiplasmodial activity of extracts and fractions from seven
medicinal plants used in the Democratic Republic of Congo. J.
Ethnopharmacol. 2004 ; 93 : 27-32.
62 – Mouchet J, Carnevale P, Coosemans M, Julvez J, Manguin S,
Richard-Lenoble D, Sircoulon J – Biodiversité du paludisme dans le
monde. John Libbey Eurotext éd., Montrouge, France 2004,
124-6.
63 – Institut de veille sanitaire – Recommandations sanitaires pour
les voyageurs 2006 (à l’intention des professionnels de santé). BEH
2006, n° 23-24, 154-63.
|
 |
|
 |